*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ British/JJ biologists/NNS ]
said/VBD 
[ they/PRP ]
developed/VBD 
[ a/DT shortcut/NN ]
for/IN 
[ making/VBG artificial/JJ antibody/NN parts/NNS ]

[ that/WDT ]
promises/VBZ to/TO become/VB 
[ a/DT basic/JJ tool/NN ]
in/IN 
[ biotechnology/NN ]
./. 

======================================

[ Researchers/NNS ]
in/IN  
[ Cambridge/NNP ]
,/, 
[ England/NNP ]
,/, said/VBD 
[ they/PRP ]
devised/VBD 
[ a/DT laboratory/NN technique/NN ]

[ that/WDT ]
can/MD make/VB 
[ key/JJ parts/NNS ]
of/IN 
[ animal/NN antibody/NN molecules/NNS ]
in/IN as/RB little/JJ as/IN 
[ three/CD days/NNS ]
./. 

[ Today/NN ]
's/POS 
[ most/RBS common/JJ technology/NN ]
for/IN 
[ the/DT task/NN ]
--/: widely/RB used/JJ 
[ monoclonal/JJ antibodies/NNS ]
--/: typically/RB takes/VBZ 
[ a/DT month/NN ]
or/CC 
[ more/JJR ]
./. 

[ The/DT new/JJ method/NN ]
will/MD likely/RB speed/VB 
[ development/NN ]
of/IN 
[ medical/JJ diagnostic/JJ products/NNS ]
,/, and/CC has/VBZ already/RB stirred/VBN 
[ intense/JJ interest/NN ]
among/IN 
[ major/JJ drug/NN companies/NNS ]
./. 

======================================

More/RBR significantly/RB ,/, 
[ the/DT British/JJ discovery/NN ]
brings/VBZ 
[ the/DT world/NN biotechnology/NN industry/NN ]
closer/RBR to/TO 
[ its/PRP$ goal/NN ]
of/IN being/VBG 
[ able/JJ ]
to/TO fabricate/VB 
[ designer/NN antibodies/NNS ]
at/IN 
[ will/NN ]
--/: 
[ an/DT achievement/NN ]

[ that/WDT ]
would/MD greatly/RB speed/VB 
[ drug/NN research/NN ]
./. 

``/`` 
[ What/WP ]
 
{/( 
[ the/DT British/NNP team/NN ]
 }/) has/VBZ done/VBN is/VBZ 
[ a/DT very/RB important/JJ step/NN ]
in/IN 
[ this/DT technology/NN ]
,/, ''/'' said/VBD 
[ Richard/NNP Lerner/NNP ]
,/, 
[ director/NN ]
of/IN 
[ the/DT Scripps/NNP Clinic/NNP 's/POS research/NN institute/NN ]
,/, 
[ a/DT La/NNP Jolla/NNP ]
,/, 
[ Calif./NNP ]
,/, 
[ nonprofit/JJ organization/NN ]

[ that/WDT ]
has/VBZ been/VBN pursuing/VBG 
[ similar/JJ research/NN ]
./. 

======================================

[ The/DT new/JJ method/NN ]
was/VBD developed/VBN by/IN 
[ scientists/NNS ]
at/IN 
[ Cambridge/NNP 's/POS Laboratory/NNP ]
of/IN 
[ Molecular/NNP Biology/NNP ]
,/, 
[ the/DT same/JJ lab/NN ]
where/WRB 
[ monoclonal-antibody/NN technology/NN ]
was/VBD invented/VBN in/IN 
[ 1975/CD ]
./. 

Called/VBN ``/`` 
[ single-domain/JJ antibodies/NNS ]
,/, ''/'' 
[ the/DT method/NN ]
strings/VBZ together/RB 
[ several/JJ already-known/JJ laboratory/NN techniques/NNS ]
to/TO manufacture/VB 
[ artificial/JJ antibody/NN parts/NNS ]
./. 

Although/IN 
[ other/JJ scientists/NNS ]
have/VBP been/VBN working/VBG on/IN 
[ similar/JJ research/NN ]
,/, 
[ the/DT British/JJ team/NN ]
is/VBZ 
[ the/DT first/JJ ]
to/TO publish/VB 
[ research/NN ]
demonstrating/VBG 
[ such/JJ methods/NNS ]
can/MD produce/VB 
[ a/DT potent/JJ working/VBG antibody/NN ]
./. 

[ Their/PRP$ paper/NN ]
is/VBZ to/TO be/VB published/VBN in/IN 
[ today/NN 's/POS edition/NN ]
of/IN 
[ Nature/NNP ]
,/, 
[ the/DT British/JJ scientific/JJ journal/NN ]
./. 

======================================

[ Antibody/NN molecules/NNS ]
are/VBP 
[ the/DT body/NN 's/POS front-line/JJ defense/NN ]
against/IN 
[ disease/NN ]
./. 

[ They/PRP ]
seek/VBP out/RB and/CC bind/VBP with/IN invading/VBG 
[ bacteria/NNS ]
or/CC 
[ toxins/NNS ]
,/, activating/VBG 
[ the/DT body/NN 's/POS immune/JJ system/NN ]
./. 

Since/IN 
[ 1975/CD ]
,/, 
[ the/DT most/RBS common/JJ method/NN ]
for/IN 
[ manufacturing/VBG artificial/JJ antibodies/NNS ]
--/: used/VBN in/IN 
[ diagnostic/JJ products/NNS ]
,/, 
[ medicines/NNS ]
and/CC 
[ chemical/NN analysis/NN ]
--/: has/VBZ been/VBN to/TO fuse/VB 
[ an/DT antibody-producing/JJ cell/NN ]
with/IN 
[ a/DT cancerous/JJ cell/NN ]
./. 

[ The/DT resulting/VBG cell/NN ]
multiplies/VBZ like/IN 
[ its/PRP$ cancerous/JJ parent/NN ]
but/CC also/RB produces/VBZ 
[ antibodies/NNS ]
./. 

[ Lab/NN technicians/NNS ]
then/RB harvest/VBP 
[ the/DT product-monoclonal/JJ antibodies/NNS ]
./. 

======================================

[ The/DT Cambridge/NNP team/NN ]
skipped/VBD 
[ that/DT long/JJ process/NN ]
entirely/RB ./. 

Instead/RB ,/, 
[ they/PRP ]
worked/VBD with/IN 
[ the/DT genes/NNS ]

[ the/DT body/NN ]
uses/VBZ when/WRB making/VBG 
[ its/PRP$ own/JJ antibodies/NNS ]
./. 

[ An/DT antibody/NN molecule/NN ]
has/VBZ 
[ three/CD parts/NNS ]
:/: 
[ a/DT constant/JJ portion/NN ]

[ that/WDT ]
's/VBZ identical/JJ in/IN 
[ all/DT antibodies/NNS ]
and/CC alerts/VBZ 
[ the/DT immune/JJ system/NN ]
;/: and/CC 
[ two/CD ]
widely/RB varying/VBG 
[ segments/NNS ]
tailored/VBN to/TO recognize/VB and/CC bind/VB with/IN 
[ specific/JJ foreign/JJ intruders/NNS ]
./. 

[ Each/DT antibody-making/JJ cell/NN ]
has/VBZ 
[ genes/NNS ]
controlling/VBG 
[ the/DT production/NN ]
of/IN 
[ these/DT segments/NNS ]
./. 

======================================

[ The/DT Cambridge/NNP team/NN ]
isolated/VBD 
[ the/DT genes/NNS ]
for/IN 
[ one/CD ]
of/IN 
[ the/DT varying/VBG antibody/NN segments/NNS ]
,/, 
[ the/DT so-called/JJ heavy/JJ chain/NN ]
,/, and/CC used/VBD 
[ standard/JJ lab/NN techniques/NNS ]
to/TO make/VB 
[ thousands/NNS ]
of/IN 
[ gene/NN copies/NNS ]
./. 

[ They/PRP ]
then/RB inserted/VBD 
[ the/DT gene/NN copies/NNS ]
into/IN 
[ common/JJ laboratory/NN bacteria/NNS ]
./. 

[ The/DT bacteria/NNS ]
,/, treating/VBG 
[ the/DT new/JJ genes/NNS ]
as/IN 
[ their/PRP$ own/JJ ]
,/, quickly/RB produced/VBD 
[ the/DT heavy/JJ chains/NNS ]
./. 

When/WRB 
[ the/DT scientists/NNS ]
tested/VBD 
[ the/DT heavy/JJ chains/NNS ]
,/, 
[ they/PRP ]
found/VBD 
[ they/PRP ]
bound/VBN almost/RB as/RB well/RB to/TO 
[ their/PRP$ ]
intended/JJ 
[ foreign/JJ targets/NNS ]
as/IN did/VBD 
[ the/DT original/JJ complete/JJ antibody/NN molecules/NNS ]
./. 

[ Their/PRP$ effectiveness/NN ]
was/VBD comparable/JJ to/TO 
[ that/DT ]
of/IN 
[ monoclonal/JJ antibodies/NNS ]
./. 

======================================

[ Some/DT products/NNS ]
may/MD be/VB immediately/RB possible/JJ ./. 

For/IN 
[ instance/NN ]
,/, 
[ a/DT Nature/NNP commentary/NN ]
suggested/VBD 
[ that/DT such/JJ heavy/JJ chains/NNS ]
could/MD be/VB tailored/VBN to/TO find/VB and/CC eliminate/VB 
[ unwanted/JJ chemicals/NNS ]
in/IN 
[ the/DT blood/NN ]
,/, such/JJ as/IN 
[ medicine/NN overdoses/NNS ]
./. 

But/CC 
[ further/JJR research/NN ]
is/VBZ already/RB under/IN 
[ way/NN ]
to/TO improve/VB 
[ the/DT technolology/NN ]
./. 

[ The/DT Scripps/NNP team/NN ]
,/, collaborating/VBG with/IN 
[ Stratagene/NNP Inc./NNP ]
,/, 
[ La/NNP Jolla/NNP ]
,/, 
[ Calif./NNP ]
,/, is/VBZ developing/VBG 
[ a/DT variant/JJ method/NN ]
to/TO allow/VB 
[ rapid/JJ production/NN ]
of/IN 
[ both/DT ]

[ the/DT heavy/JJ chain/NN ]
and/CC 
[ the/DT other/JJ variable/JJ antibody/NN segment/NN ]
,/, 
[ the/DT so-called/JJ light/JJ chain/NN ]
./. 

======================================

Ultimately/RB ,/, said/VBD 
[ Scripps/NNP 's/POS Mr./NNP Lerner/NNP ]
,/, 
[ such/JJ technology/NN ]
may/MD allow/VB 
[ scientists/NNS ]
to/TO build/VB 
[ a/DT library/NN ]
of/IN 
[ artificial/JJ antibody/NN parts/NNS ]

[ that/WDT ]
could/MD be/VB tapped/VBN quickly/RB for/IN 
[ research/NN ]
against/IN 
[ any/DT disease/NN ]
./. 

[ Commercial/JJ interest/NN ]
is/VBZ intense/JJ ./. 

[ Several/JJ companies/NNS ]
,/, including/VBG 
[ Britain/NNP 's/POS Wellcome/NNP PLC/NNP ]
and/CC 
[ West/NNP Germany/NNP 's/POS Behringwerke/NNP AG/NNP ]
,/, are/VBP in/IN 
[ contact/NN ]
with/IN 
[ the/DT lab/NN 's/POS government/NN overseer/NN ]
about/IN 
[ possible/JJ further/JJ collaboration/NN ]
./. 
